Cytonus Therapeutics
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
4
Funding Rounds
$2.6m
Money raised
Overview
Cytonus Therapeutics is a biotechnology company developing adaptive cellular therapies for treating immune-oncology and inflammatory diseases.
-
Website:
- Business model: B2C
- Social accounts:
Funding series
Funding Series Analysis
The company Cytonus Therapeutics has raised a total of $1m in funding over 4 rounds.
Key Insights:
- Cytonus Therapeutics Funding Round, February 2022: $1m
- Cytonus Therapeutics Grant (money), September 2020: $400k
- Cytonus Therapeutics Grant (money), June 2020: $400k
- Cytonus Therapeutics Convertible note, February 2019: $800k
Cytonus Therapeutics Funding Round, February 2022
$1m
Cytonus Therapeutics Grant (money), September 2020
$400k
Cytonus Therapeutics Grant (money), June 2020
$400k
Cytonus Therapeutics Convertible note, February 2019
$800k
Industries
Cytonus Therapeutics is active in the following industries: